Blue Sparrow LLC’s CME Group CME Stock Holding History

Blue Sparrow LLC’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-28,069	Closed	-$8.29M	–	137
2026 Q1	$8.29M	Hold	28,069	–	–	0.14%	64
2025 Q4	$7.67M	Buy	+28,069	New	+$7.63M	0.14%	81

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Blue Sparrow LLC's CME Position: Q2 2026 in Review

Blue Sparrow LLC sold out of CME Group (CME) in Q2 2026, closing a stake of 28,069 shares — an estimated $8.29M sold.

Blue Sparrow LLC first reported a position in CME in Q4 2025 and held it in 2 quarters. The position peaked at $8.29M in Q1 2026. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Blue Sparrow LLC reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Blue Sparrow LLC sold 28,069 CME Group shares in Q2 2026, an estimated $8.29M.
Blue Sparrow LLC first reported a position in CME Group in Q4 2025 and held it in 2 quarters.
Blue Sparrow LLC's CME Group position peaked at $8.29M in Q1 2026.
1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Blue Sparrow LLC's 13F filing for Q2 2026, filed 14 Aug 2026.